Kursinformation
Für dieses Unternehmen ist kein Kurs-Chart verfügbar.
()
Aktuelle News
News Funktionen
Weitere Funktionen
4 April 2024
12:30
Corporate
EN
Immunic AG
Corporate
EN
Immunic to Host MS R&D Day and Participate in Investor Conferences in April
20 März 2024
11:30
Corporate
EN
Immunic AG
Corporate
EN
Immunic Receives Notice of Allowance for Composition-of-Matter Patent of a Specific Polymorph of Vidofludimus Calcium in the United States
7 März 2024
12:30
Corporate
EN
Immunic AG
Corporate
EN
Immunic to Participate in Investor and Scientific Conferences in March
29 Februar 2024
12:30
Corporate
EN
Immunic AG
Corporate
EN
Immunic Presents Data From Phase 2 CALLIPER and CALVID-1 Trials of Vidofludimus Calcium at the ACTRIMS Forum 2024
22 Februar 2024
12:30
Corporate
EN
Immunic AG
Corporate
EN
Immunic, Inc. Reports Year End 2023 Financial Results and Provides Corporate Update
15 Februar 2024
12:30
Corporate
EN
Immunic AG
Corporate
EN
Immunic, Inc. to Announce Financial Results for the Year Ended December 31, 2023, and Provide Corporate Update